The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 17, 2013
Filed:
Aug. 03, 2010
Mariappan V. Chelliah, Edison, NJ (US);
Samuel Chackalamannil, Califon, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Keith Eagan, Kenilworth, NJ (US);
Zhuyan Guo, Scotch Plains, NJ (US);
Martin C. Clasby, Plainsboro, NJ (US);
Yan Xia, Edison, NJ (US);
Charles L. Jayne, Staten Island, NY (US);
Michael Dwyer, Scotch Plains, NJ (US);
Kartik M. Keertikar, East Windsor, NJ (US);
Tin-yau Chan, Edison, NJ (US);
LI Wang, Nanuet, NY (US);
Mariappan V. Chelliah, Edison, NJ (US);
Samuel Chackalamannil, Califon, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Keith Eagan, Kenilworth, NJ (US);
Zhuyan Guo, Scotch Plains, NJ (US);
Martin C. Clasby, Plainsboro, NJ (US);
Yan Xia, Edison, NJ (US);
Charles L. Jayne, Staten Island, NY (US);
Michael Dwyer, Scotch Plains, NJ (US);
Kartik M. Keertikar, East Windsor, NJ (US);
Tin-Yau Chan, Edison, NJ (US);
Li Wang, Nanuet, NY (US);
Merck Sharp & Dohme, Corp., Rahway, NJ (US);
Abstract
The present invention relates to novel heterocyclic compounds of Formulae (I): (Chemical formula should be inserted here as it appears on abstract in paper form) Formula (I) as disclosed herein, or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are pharmaceutical compositions comprising said compounds, and methods for using said compounds for treating or preventing a thromboembolic disorder.